Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revive Therapeutics Ltd (OP:RVVTF)

0.0088 +0.0003 (+3.53%)
Streaming Delayed Price Updated: 11:03 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Revive Therapeutics Ltd

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.29% at $0.20 
Via Benzinga
News headline image
Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.29% at $0.19 
Via Benzinga
News headline image
Mind Medicine, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 5.04% at $0.17 
Via Benzinga
News headline image
Mindset Pharma, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 15.70% at $0.69 
Via Benzinga
News headline image
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.89% at $5.33 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 28, 2022 ↗
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 17.86% at $0.57 
Via Benzinga
News headline image
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 6.29% at $0.49 
Via Benzinga
News headline image
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC: 
Via Benzinga
News headline image
Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 24, 2022 ↗
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 21, 2022 ↗
GAINERS: GH Research (NASDAQ: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 20, 2022 ↗
GAINERS: Small Pharma (OTC: 
Via Benzinga
News headline image
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: Revive Therapeutics (OTC: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 18, 2022 ↗
GAINERS: Cybin (AMEX: 
Via Benzinga
News headline image
Marijuana & Psychedelic Drug Stocks Continue To Decline ↗
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are... 
Via Talk Markets
News headline image
Marijuana & Psychedelic Compounds-Based Drug Stocks Now Down -16% YTD ↗
A look at which index has done the best so far in December: the Marijuana Drug Stocks Index or the Psychedelic Compounds-Based Drug Stocks Index. 
Via Talk Markets
News headline image
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November ↗
A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance. 
Via Talk Markets
Topics Cannabis
News headline image
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval ↗
Detroit Decriminalizes Psychedelics 
Via Benzinga
News headline image
September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances ↗
Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? 
Via Talk Markets
News headline image
Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September ↗
Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? 
Via Talk Markets
Topics Cannabis
News headline image
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗
The Week In Psychedelics 
Via Benzinga
News headline image
Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week ↗
The performance of the psychedelic-focused index components substantially outshone the weed stocks. 
Via Talk Markets
Topics Cannabis
News headline image
Marijuana Drug Stocks: All You Need To Know Is Here! ↗
Eight clinical-stage companies researching the treatment of a wide variety of illnesses using marijuana of which 6 have market capitalizations in excess of $50M and less than $500M and 2 have market... 
Via Talk Markets
Topics Cannabis
News headline image
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
News headline image
These OTC Securities Had the Most Trading Activity in July ↗
Photo by Federico Beccari on Unsplash In July, O... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
News headline image
Marijuana And Mushroom Stock Category Down 4% In July; Now +24% YTD ↗
We detail how he pot- and psychedelic-related stock sector performed in the last week, during the month of July, and YTD and the stocks that moved +/-5% last week, and why. 
Via Talk Markets
Topics Cannabis
News headline image
Marijuana Vs. Mushroom Psychedelic Drug Stocks: A Current & YTD Performance Comparison ↗
We identify the performance of the top 8 clinical-stage psychedelic companies in each of the marijuana and mushroom drug stock categories during the past 5 trading days, July to date, and YTD. 
Via Talk Markets
Topics Cannabis
News headline image
Pot Stocks Down In June - Remain +29.6% YTD ↗
There are four cannabis/cannabis-related pot stock categories which I use to provide the clearest overview of the cannabis stock sector that is available anywhere. Below is a comparison of how each... 
Via Talk Markets
Topics Cannabis
News headline image
The Cannabis-Centric BioPharma Stocks Index Declined In April But Remains Up YTD ↗
13 cannabis-centric clinical-stage biopharmaceutical companies and their major operational activities in April to assist those considering investing in this marijuana sub-category, 
Via Talk Markets
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.